Samsung Organoids to provide data-driven analysis of candidate molecules Samsung Biologics expands service scope to include preclinical research INCHEON, South Korea, June 15, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing…
